182 related articles for article (PubMed ID: 12444818)
21. An open-label trial of acamprosate in the treatment of pathological gambling.
Black DW; McNeilly DP; Burke WJ; Shaw MC; Allen J
Ann Clin Psychiatry; 2011 Nov; 23(4):250-6. PubMed ID: 22073381
[TBL] [Abstract][Full Text] [Related]
22. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
Kim SW; Grant JE; Potenza MN; Blanco C; Hollander E
Psychiatry Res; 2009 Mar; 166(1):76-84. PubMed ID: 19200607
[TBL] [Abstract][Full Text] [Related]
23. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC; Zaninelli R
J Clin Psychiatry; 2002 Jun; 63(6):501-7. PubMed ID: 12088161
[TBL] [Abstract][Full Text] [Related]
24. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
[TBL] [Abstract][Full Text] [Related]
25. Open trial of nefazodone for combat-related posttraumatic stress disorder.
Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
J Clin Psychiatry; 1998 Sep; 59(9):460-4. PubMed ID: 9771816
[TBL] [Abstract][Full Text] [Related]
26. Nefazodone for chronic daily headache prophylaxis: an open-label study.
Saper JR; Lake AE; Tepper SJ
Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644
[TBL] [Abstract][Full Text] [Related]
27. Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation.
Koran LM; Chuong HW; Bullock KD; Smith SC
J Clin Psychiatry; 2003 Jul; 64(7):793-8. PubMed ID: 12934980
[TBL] [Abstract][Full Text] [Related]
28. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.
Grant JE; Chamberlain SR; Odlaug BL; Potenza MN; Kim SW
Psychopharmacology (Berl); 2010 Dec; 212(4):603-12. PubMed ID: 20721537
[TBL] [Abstract][Full Text] [Related]
29. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
Dannon PN; Lowengrub K; Musin E; Gonopolski Y; Kotler M
J Clin Psychopharmacol; 2005 Dec; 25(6):593-6. PubMed ID: 16282845
[TBL] [Abstract][Full Text] [Related]
30. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
31. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
Saiz-Ruiz J; Ibañez A; Díaz-Marsá M; Arias F; Carrasco JL; Huertas D; Martín-Carrasco M; Moreno I; Rico-Villademoros F
CNS Drugs; 2002; 16(9):635-43. PubMed ID: 12153334
[TBL] [Abstract][Full Text] [Related]
32. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
Dannon PN; Lowengrub K; Musin E; Gonopolsky Y; Kotler M
J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130
[TBL] [Abstract][Full Text] [Related]
33. Demographic and clinical features of 131 adult pathological gamblers.
Grant JE; Kim SW
J Clin Psychiatry; 2001 Dec; 62(12):957-62. PubMed ID: 11780876
[TBL] [Abstract][Full Text] [Related]
34. Dual psychiatric diagnosis and substance abuse in pathological gamblers: a preliminary gender comparison study.
Dannon PN; Lowengrub K; Shalgi B; Sasson M; Tuson L; Saphir Y; Kotler M
J Addict Dis; 2006; 25(3):49-54. PubMed ID: 16956869
[TBL] [Abstract][Full Text] [Related]
35. Nefazodone in social phobia.
Van Ameringen M; Mancini C; Oakman JM
J Clin Psychiatry; 1999 Feb; 60(2):96-100. PubMed ID: 10084635
[TBL] [Abstract][Full Text] [Related]
36. Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study.
Coleman E; Gratzer T; Nesvacil L; Raymond NC
J Clin Psychiatry; 2000 Apr; 61(4):282-4. PubMed ID: 10830149
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of pharmacotherapy for pathological gambling: a chart review.
Grant JE; Kim SW
Ann Clin Psychiatry; 2002 Sep; 14(3):155-61. PubMed ID: 12585565
[TBL] [Abstract][Full Text] [Related]
38. The relationship of DSM-IV pathological gambling to compulsive buying and other possible spectrum disorders: results from the Iowa PG family study.
Black DW; Coryell W; Crowe R; Shaw M; McCormick B; Allen J
Psychiatry Res; 2015 Mar; 226(1):273-6. PubMed ID: 25660732
[TBL] [Abstract][Full Text] [Related]
39. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
Sánchez-Lacay JA; Lewis-Fernández R; Goetz D; Blanco C; Salmán E; Davies S; Liebowitz M
Depress Anxiety; 2001; 13(3):118-24. PubMed ID: 11387731
[TBL] [Abstract][Full Text] [Related]
40. An open-label study of naltrexone in the treatment of kleptomania.
Grant JE; Kim SW
J Clin Psychiatry; 2002 Apr; 63(4):349-56. PubMed ID: 12000210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
